These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 12851511

  • 1. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V, Sarti CD, Fornaro F, Farzati A, De Franciscis P, Sepe E, Borrelli AL, Colacurci N.
    Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
    [Abstract] [Full Text] [Related]

  • 2. Effect of hormone therapy on the enteroinsular axis.
    Sztefko K, Rogatko I, Milewicz T, Józef K, Tomasik PJ, Szafran Z.
    Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
    [Abstract] [Full Text] [Related]

  • 3. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T, Kostecka A, Rogatko I, Sztefko K, Kwiatkowska-Panek E, Radowick S, Krzysiek J.
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [Abstract] [Full Text] [Related]

  • 4. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 5. Effect of oral or transdermal hormone replacement therapy on homocysteine levels: a randomized clinical trial.
    Bruschi F, Dal Pino D, Fiore V, Parazzini F, Di Pace R, Cesana BM, Melotti D, Crosignani PG.
    Maturitas; 2004 May 28; 48(1):33-8. PubMed ID: 15223106
    [Abstract] [Full Text] [Related]

  • 6. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S, Mercuri A, Prontera C, Zucchelli GC, Vassalle C.
    Climacteric; 2006 Dec 28; 9(6):452-8. PubMed ID: 17085378
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study.
    Kurtay G, Ozmen B.
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb 28; 130(2):206-11. PubMed ID: 16814449
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of low-dose 17beta-estradiol plus dydrogesterone on 24-h ambulatory blood pressure in healthy postmenopausal women: a 1-year, randomized, prospective study.
    Kaya C, Cengiz SD, Cengiz B, Akgun G.
    Gynecol Endocrinol; 2007 Oct 28; 23 Suppl 1():62-7. PubMed ID: 17943541
    [Abstract] [Full Text] [Related]

  • 9. The effect of postmenopausal hormone therapy with or without folic acid supplementation on serum homocysteine level.
    Toprak A, Erenus M, Ilhan AH, Haklar G, Fak AS, Oktay A.
    Climacteric; 2005 Sep 28; 8(3):279-86. PubMed ID: 16390760
    [Abstract] [Full Text] [Related]

  • 10. Hormone replacement influences homocysteine levels in the methionine-loading test: a randomized placebo controlled trial in postmenopausal women.
    Smolders RG, de Meer K, Kenemans P, Teerlink T, Jakobs C, van der Mooren MJ.
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov 10; 117(1):55-9. PubMed ID: 15474245
    [Abstract] [Full Text] [Related]

  • 11. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
    Lippuner K, Haenggi W, Birkhaeuser MH, Casez JP, Jaeger P.
    J Bone Miner Res; 1997 May 10; 12(5):806-12. PubMed ID: 9144347
    [Abstract] [Full Text] [Related]

  • 12. [Effect of hormone replacement therapy on homocysteine and echocardiography in postmenopausal women].
    Hui Y, Wu Y, Xiao L, Tang Z, Wu Y, Li Y.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Oct 10; 37(10):598-600. PubMed ID: 12487933
    [Abstract] [Full Text] [Related]

  • 13. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J, Sumino H, Ichikawa S, Ozaki M.
    Am J Hypertens; 2006 Jul 10; 19(7):744-9. PubMed ID: 16814131
    [Abstract] [Full Text] [Related]

  • 14. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H, Odabasi AR, Demircan S, Köseoğlu K, Kizilkaya K, Onur E.
    Gynecol Endocrinol; 2007 Feb 10; 23(2):99-104. PubMed ID: 17454160
    [Abstract] [Full Text] [Related]

  • 15. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA, Farias ML, Andrade AT.
    Climacteric; 2002 Sep 10; 5(3):286-92. PubMed ID: 12419087
    [Abstract] [Full Text] [Related]

  • 16. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G, Ozmen B, Erguder I.
    Maturitas; 2006 Jan 10; 53(1):32-8. PubMed ID: 16325022
    [Abstract] [Full Text] [Related]

  • 17. The long-term effects of low-dose 17beta-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study.
    Kaya C, Dinçer Cengiz S, Cengiz B, Akgün G.
    Climacteric; 2006 Dec 10; 9(6):437-45. PubMed ID: 17085376
    [Abstract] [Full Text] [Related]

  • 18. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F, Terek MC, Karadadaş N, Bilgin O.
    J Reprod Med; 2001 Nov 10; 46(11):962-8. PubMed ID: 11762152
    [Abstract] [Full Text] [Related]

  • 19. Effects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal women.
    Kessel H, Kamp O, Kenemans P, Mijatovic V, van Baal WM, Visser CA, van der Mooren MJ.
    Am J Obstet Gynecol; 2001 Apr 10; 184(5):910-6. PubMed ID: 11303198
    [Abstract] [Full Text] [Related]

  • 20. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
    Chu MC, Cosper P, Nakhuda GS, Lobo RA.
    Fertil Steril; 2006 Dec 10; 86(6):1669-75. PubMed ID: 17074346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.